Branching Misunderstandings: When Chemistry Meets Legalese in Alnylam v. Moderna
The clash between these two companies spotlights a fascinating intersection of chemical innovation and patent law and serves as a reminder for the biotech and pharmaceutical industries that even the smallest details can have outsized consequences.